Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 6 | 100% |
Develops protein-based biopharmaceutical products for chronic inflammatory diseases and oncology
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 6 | 100% |